Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.56
-0.17 (-1.58%)
Aug 27, 2026, 4:08 PM HKT

Xuanzhu Biopharmaceutical Statistics

Total Valuation

HKG:2575 has a market cap or net worth of HKD 5.56 billion. The enterprise value is 4.97 billion.

Market Cap5.56B
Enterprise Value 4.97B

Important Dates

The last earnings date was Wednesday, August 26, 2026.

Earnings Date Aug 26, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2575 has 517.95 million shares outstanding. The number of shares has increased by 9.66% in one year.

Current Share Class 517.95M
Shares Outstanding 517.95M
Shares Change (YoY) +9.66%
Shares Change (QoQ) +6.30%
Owned by Insiders (%) 2.18%
Owned by Institutions (%) 4.51%
Float 120.75M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 46.59
PB Ratio 3.72
P/TBV Ratio 7.86
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 41.67
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.00.

Current Ratio 3.69
Quick Ratio 2.73
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,902.27

Financial Efficiency

Return on equity (ROE) is -19.61% and return on invested capital (ROIC) is -11.77%.

Return on Equity (ROE) -19.61%
Return on Assets (ROA) -9.64%
Return on Invested Capital (ROIC) -11.77%
Return on Capital Employed (ROCE) -14.99%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 348,772
Profits Per Employee -708,684
Employee Count342
Asset Turnover 0.08
Inventory Turnover 1.04

Taxes

In the past 12 months, HKG:2575 has paid 6,927 in taxes.

Income Tax 6,927
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 12.84
200-Day Moving Average 39.89
Relative Strength Index (RSI) 35.27
Average Volume (20 Days) 425,700

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2575 had revenue of HKD 119.28 million and -242.37 million in losses. Loss per share was -0.49.

Revenue119.28M
Gross Profit 35.61M
Operating Income -232.79M
Pretax Income -242.36M
Net Income -242.37M
EBITDA -199.24M
EBIT -232.79M
Loss Per Share -0.49
Full Income Statement

Balance Sheet

The company has 587.01 million in cash and 251,675 in debt, with a net cash position of 586.76 million or 1.13 per share.

Cash & Cash Equivalents 587.01M
Total Debt 251,675
Net Cash 586.76M
Net Cash Per Share 1.13
Equity (Book Value) 1.49B
Book Value Per Share 2.98
Working Capital 632.80M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 33.88M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 29.85%, with operating and profit margins of -195.16% and -203.19%.

Gross Margin 29.85%
Operating Margin -195.16%
Pretax Margin -203.19%
Profit Margin -203.19%
EBITDA Margin -167.04%
EBIT Margin -195.16%
FCF Margin n/a

Dividends & Yields

HKG:2575 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.66%
Shareholder Yield -9.66%
Earnings Yield -4.36%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1